Submitted by Anonymous (not verified) on Wed, 10/31/2018 - 07:25
High hopes, hype for experimental depression drug ketamineHonolulu Star-AdvertiserLast year, Sanacora co-authored an American Psychiatric Association task force review of ketamine treatment for mood disorders that noted the benefits but said “major gaps” remain in knowledge